{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T10:41:05Z","timestamp":1775904065310,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1016\/j.clinthera.2007.06.017","type":"journal-article","created":{"date-parts":[[2007,8,9]],"date-time":"2007-08-09T11:38:50Z","timestamp":1186659530000},"page":"1168-1177","source":"Crossref","is-referenced-by-count":26,"title":["Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit\/hyperactivity disorder\u2014A preliminary tolerability and efficacy study"],"prefix":"10.1016","volume":"29","author":[{"given":"Humberto","family":"Quintana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward A.","family":"Cherlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Duesenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark E.","family":"Bangs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet L.","family":"Ramsey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter D.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert J.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas K.","family":"Kelsey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2007.06.017_bib1","series-title":"Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision: DSM-IV-TR","year":"2000"},{"key":"10.1016\/j.clinthera.2007.06.017_bib2","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1097\/00004583-200012000-00014","article-title":"Comparison of attention-deficit\/hyperactivity disorder symptom subtypes in Ukrainian schoolchildren","volume":"39","author":"Gadow","year":"2000","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.clinthera.2007.06.017_bib3","series-title":"The clinical effectiveness and cost-effectiveness of methylphenidate for hyperactivity in childhood","author":"Lord","year":"2000"},{"key":"10.1016\/j.clinthera.2007.06.017_bib4","series-title":"International Statistical Classification of Diseases and Related Health Problems, Tenth Revision","author":"World Health Organization (WHO)","year":"2004"},{"key":"10.1016\/j.clinthera.2007.06.017_bib5","series-title":"International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM)","author":"US Dept of Health and Human Services","year":"2007"},{"key":"10.1016\/j.clinthera.2007.06.017_bib6","series-title":"Attention-Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment","author":"Barkley","year":"1998"},{"key":"10.1016\/j.clinthera.2007.06.017_bib7","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1542\/peds.92.2.212","article-title":"Driving-related risks and outcomes of attention deficit hyperactivity disorder in adolescents and young adults: A 3-to 5-year follow-up survey","volume":"92","author":"Barkley","year":"1993","journal-title":"Pediatrics"},{"key":"10.1016\/j.clinthera.2007.06.017_bib8","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1939-0025.1984.tb01507.x","article-title":"Hyperactives as young adults: Past and current substance abuse and antisocial behavior","volume":"54","author":"Hechtman","year":"1984","journal-title":"Am J Orthopsychiatry"},{"key":"10.1016\/j.clinthera.2007.06.017_bib9","series-title":"Presented at: The 51st Annual Meeting of the American Academy of Child and Adolescent Psychiatry","article-title":"Differential response to stimulants and atomoxetine","author":"Newcorn","year":"2004"},{"key":"10.1016\/j.clinthera.2007.06.017_bib10","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.1542\/peds.107.1.e10","article-title":"Placebo-controlled evaluation of amphetamine mixture-dextroamphetamine salts and amphetamine salts (Adderall): Efficacy rate and side effects","volume":"107","author":"Ahmann","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.clinthera.2007.06.017_bib11","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1542\/peds.100.4.662","article-title":"Side effects of methylphenidate and dexamphetamine in children with attention deficit hyperactivity disorder: A double-blind, crossover trial","volume":"100","author":"Efron","year":"1997","journal-title":"Pediatrics"},{"key":"10.1016\/j.clinthera.2007.06.017_bib12","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/00004583-199905000-00011","article-title":"Stimulant medications","volume":"38","author":"Greenhill","year":"1999","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.clinthera.2007.06.017_bib13","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/00004583-199604000-00008","article-title":"Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle","volume":"35","author":"Spencer","year":"1996","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.clinthera.2007.06.017_bib14","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00787-004-0401-3","article-title":"for the Stomoxetine International Study Group. A prospective, multi-center, open-label assessment of atomoxetine in non-North American children and adolescents with ADHD","volume":"13","author":"Buitelaar","year":"2004","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"10.1016\/j.clinthera.2007.06.017_bib15","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1542\/peds.114.1.e1","article-title":"Once-daily atomoxetine treatment for children with attention-deficit\/hyperactivity disorder, including an assessment of evening and morning behavior: A double-blind, placebo-controlled trial","volume":"114","author":"Kelsey","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.clinthera.2007.06.017_bib16","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/00004583-200105000-00010","article-title":"Psychostimulants in preschool children with attention-deficit\/hyperactivity disorder: Clinical evidence from a developmental disorders institution","volume":"40","author":"Ghuman","year":"2001","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.clinthera.2007.06.017_bib17","first-page":"1475","article-title":"How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis","volume":"165","author":"Schachter","year":"2001","journal-title":"CMAJ"},{"key":"10.1016\/j.clinthera.2007.06.017_bib18","article-title":"Diagnostic and Statistical Manual of Mental Disorders: DSM-IV","year":"1994"},{"key":"10.1016\/j.clinthera.2007.06.017_bib19","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1097\/00004583-199707000-00021","article-title":"Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime version (K-SADS-PL): Initial reliability and validity data","volume":"36","author":"Kaufman","year":"1997","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.clinthera.2007.06.017_bib20","series-title":"As adopted by the 18th General Assembly","article-title":"Declaration of Helsinki: Recommendations Guiding Medical Doctors in Biomedical Research Involving Human Subjects","year":"2000"},{"key":"10.1016\/j.clinthera.2007.06.017_bib21","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/j.1552-4604.1985.tb02842.x","article-title":"Single-dose and steady-state pharmacokinetics of tomoxetine in normal subjects","volume":"25","author":"Farid","year":"1985","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2007.06.017_bib22","series-title":"ADHD Rating Scale-IV: Checklists, Norms, and Clinical Interpretations","author":"DuPaul","year":"1998"},{"key":"10.1016\/j.clinthera.2007.06.017_bib23","series-title":"ECDEU Assessment Manual for Psychopharmacology, Revised. Publication ADM 76-338","author":"Guy","year":"1976"},{"key":"10.1016\/j.clinthera.2007.06.017_bib24","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1177\/009286159102500311","article-title":"The application of the principle of intention-to-treat to the analysis of clinical trials","volume":"25","author":"Gillings","year":"1991","journal-title":"Drug Info J"},{"key":"10.1016\/j.clinthera.2007.06.017_bib25","doi-asserted-by":"crossref","first-page":"E6","DOI":"10.1542\/peds.100.6.e6","article-title":"Methylphenidate versus dextroamphetamine in children with attention deficit hyperactivity disorder: A double-blind, crossover trial","volume":"100","author":"Efron","year":"1997","journal-title":"Pediatrics"},{"key":"10.1016\/j.clinthera.2007.06.017_bib26","doi-asserted-by":"crossref","first-page":"E43","DOI":"10.1542\/peds.103.4.e43","article-title":"A comparison of Ritalin and Adderall: Efficacy and time-course in children with attention-deficit\/hyperactivity disorder","volume":"103","author":"Pelham","year":"1999","journal-title":"Pediatrics"},{"key":"10.1016\/j.clinthera.2007.06.017_bib27","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00004583-199505000-00017","article-title":"Bupropion versus methylphenidate in the treatment of attention-deficit hyperactivity disorder","volume":"34","author":"Barrickman","year":"1995","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.clinthera.2007.06.017_bib28","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/00004714-200104000-00015","article-title":"Comparing guanfacine and dextroamphetamine for the treatment of adult attention-deficit\/hyperactivity disorder","volume":"21","author":"Taylor","year":"2001","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.clinthera.2007.06.017_bib29","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1089\/cap.2000.10.311","article-title":"Efficacy of modafinil compared with dextroamphetamine for the treatment of attention deficit\/hyperactivity disorder in adults","volume":"10","author":"Taylor","year":"2000","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.clinthera.2007.06.017_bib30","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1542\/peds.86.2.226","article-title":"Relative efficacy of long-acting stimulants on children with attention deficit-hyperactivity disorder: A comparison of standard methylphenidate, sustained-release methylphenidate, sustained-release dextroamphetame, and pemoline","volume":"86","author":"Pelham","year":"1990","journal-title":"Pediatrics"},{"key":"10.1016\/j.clinthera.2007.06.017_bib31","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1001\/archpsyc.1995.03950180020004","article-title":"A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder","volume":"52","author":"Spencer","year":"1995","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.clinthera.2007.06.017_bib32","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/00004583-199301000-00029","article-title":"Nortriptyline treatment of children with attention-deficit hyperactivity disorder and tic disorder or Tourette's syndrome","volume":"32","author":"Spencer","year":"1993","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.clinthera.2007.06.017_bib33","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/00004583-199303000-00017","article-title":"Desipramine treatment of children with attention-deficit hyperactivity disorder and tic disorder or Tourette's syndrome","volume":"32","author":"Spencer","year":"1993","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.clinthera.2007.06.017_bib34","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/00004583-199303000-00015","article-title":"Nortriptyline in the treatment of ADHD: A chart review of 58 cases","volume":"32","author":"Wilens","year":"1993","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.clinthera.2007.06.017_bib35","doi-asserted-by":"crossref","first-page":"122","DOI":"10.18553\/jmcp.2004.10.2.122","article-title":"Stimulant treatment patterns and compliance in children and adults with newly treated attention-deficit\/hyperactivity disorder","volume":"10","author":"Perwien","year":"2004","journal-title":"J Manag Care Pharm"},{"key":"10.1016\/j.clinthera.2007.06.017_bib36","series-title":"Presented at: The 50th Annual Meeting of the American Academy of Child and Adolescent Psychiatry","article-title":"Characteristics of placebo responders and remitters in pediatric ADHD clinical trials","author":"Newcorn","year":"2003"},{"key":"10.1016\/j.clinthera.2007.06.017_bib37","series-title":"Presented at: The 50th Annual Meeting of the American Academy of Child and Adolescent Psychiatry","article-title":"Pharmacogenomic screening for depressed children and adolescents","author":"Mrazek","year":"2003"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291807001762?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291807001762?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,13]],"date-time":"2023-05-13T18:46:43Z","timestamp":1684003603000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291807001762"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["S0149291807001762"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2007.06.017","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}